Prediction Models of Adnexal Masses: State-of-the-Art Review

被引:2
作者
Mina, Maria [1 ]
Kosmas, Ioannis [1 ]
Tsakiridis, Ioannis [2 ]
Mamopoulos, Apostolos [2 ]
Kalogiannidis, Ioannis [2 ]
Athanasiadis, Apostolos [2 ]
Dagklis, Themistoklis [2 ]
机构
[1] Ioannina State Gen Hosp G Chatzikosta, Dept Obstet & Gynaecol, Ioannina, Greece
[2] Aristotle Univ Thessaloniki, Fac Med, Dept Obstet & Gynaecol 3, Thessaloniki, Greece
关键词
IOTA SIMPLE RULES; OVARIAN MALIGNANCY ALGORITHM; LOGISTIC-REGRESSION MODELS; SIMPLE ULTRASOUND RULES; EPIDIDYMIS PROTEIN 4; EXTERNAL VALIDATION; SUBJECTIVE ASSESSMENT; DATA SYSTEM; GI-RADS; CA; 125;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Importance: Several predictive models and scoring systems have been developed to differentiate between benign and malignant ovarian masses, in order to guide effective management. These models use combinations of patient characteristics, ultrasound markers, and biochemical markers. Objective: The aim of this study was to describe, compare, and prioritize, according to their strengths and qualities, all the adnexal prediction models. Evidence Acquisition: This was a state-of-the-art review, synthesizing the findings of the current published literature on the available prediction models of adnexal masses. Results: The existing models include subjective assessment by expert sonographers, the International Ovarian Tumor Analysis models (logistic regression models 1 and 2, Simple Rules, 3-step strategy, and ADNEX [Assessment of Different NEoplasias in the adneXa] model), the Risk of Malignancy Index, the Risk of Malignancy Ovarian Algorithm, the Gynecologic Imaging Reporting and Data System, and the Ovarian-Adnexal Reporting and Data System. Overall, subjective assessment appears to be superior to all prediction models. However, the International Ovarian Tumor Analysis models are probably the best available methods for nonexpert examiners. The Ovarian-Adnexal Reporting and Data System is an international approach that incorporates both the common European and North American approaches, but still needs to be validated. Conclusions: Many prediction models exist for the assessment of adnexal masses. The adoption of a particular model is based on local guidelines, as well as sonographer's experience. The safety of expectant management of adnexal masses with benign ultrasound morphology is still under investigation. Target Audience: Obstetricians and gynecologists, family physicians. Learning Objectives: After participating in this activity, the learner should be better able to explain all the aspects on the available prediction models of adnexal masses; assess the available prediction models of adnexal masses in terms of their accuracy; and describe the sonographic findings of an adnexal mass and estimate the relevant malignancy risk.
引用
收藏
页码:211 / 222
页数:12
相关论文
共 75 条
  • [11] Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses
    Auekitrungrueng, Rapeepat
    Tinnangwattana, Dangcheewan
    Tantipalakorn, Charuwan
    Charoenratana, Cholaros
    Lerthiranwong, Thitikarn
    Wanapirak, Chanane
    Tongsong, Theera
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 146 (03) : 364 - 369
  • [12] Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management
    Bandiera, Elisabetta
    Romani, Chiara
    Specchia, Claudia
    Zanotti, Laura
    Galli, Claudio
    Ruggeri, Giuseppina
    Tognon, Germana
    Bignotti, Eliana
    Tassi, Renata A.
    Odicino, Franco
    Caimi, Luigi
    Sartori, Enrico
    Santin, Alessandro D.
    Pecorelli, Sergio
    Ravaggi, Antonella
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (12) : 2496 - 2506
  • [13] Gynecology Imaging Reporting and Data System (GI-RADS): diagnostic performance and inter-reviewer agreement
    Basha, Mohammad Abd Alkhalik
    Refaat, Rania
    Ibrahim, Safaa A.
    Madkour, Nadia M.
    Awad, Awad Mahmoud
    Mohamed, Elshaimaa Mohamed
    El Sammak, Ahmed A.
    Zaitoun, Mohamed M. A.
    Dawoud, Hitham A.
    Khamis, Mai E. M.
    Mohamed, Heba A. E.
    El-Maghraby, Ahmed Mohamed
    Abdalla, Ahmed A. El-Hamid M.
    Assy, Mostafa Mohamad
    Nada, Mohamad Gamal
    Obaya, Ahmed Ali
    Abdelbary, Eman H.
    [J]. EUROPEAN RADIOLOGY, 2019, 29 (11) : 5981 - 5990
  • [14] The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms
    Bingle, L
    Singleton, V
    Bingle, CD
    [J]. ONCOGENE, 2002, 21 (17) : 2768 - 2773
  • [15] Proteins with whey-aicidic-protein motifs and cancer
    Bouchard, D
    Morisset, D
    Bourbonnais, Y
    Tremblay, GM
    [J]. LANCET ONCOLOGY, 2006, 7 (02) : 167 - 174
  • [16] Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China
    Chen, H.
    Qian, L.
    Jiang, M.
    Du, Q.
    Yuan, F.
    Feng, W.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2019, 54 (06) : 815 - 822
  • [17] Diagnostic value of the International Ovarian Tumor Analysis (IOTA) simple rules versus pattern recognition to differentiate between malignant and benign ovarian masses
    Dakhly, Dina M. R.
    Gaafar, Hassan M.
    Sediek, Mona M.
    Ibrahim, Mohamed F.
    Momtaz, Mohamed
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 147 (03) : 344 - 349
  • [18] Dewan Rupali, 2019, Asian Pac J Cancer Prev, V20, P1103
  • [19] Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial
    Dochez, Vincent
    Randet, Melanie
    Renaudeau, Celine
    Dimet, Jerome
    Le Thuaut, Aurelie
    Winer, Norbert
    Thubert, Thibault
    Vaucel, Edouard
    Caillon, Helene
    Ducarme, Guillaume
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
  • [20] Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometriold ovarian carcinomas
    Drapkin, R
    von Horsten, HH
    Lin, YF
    Mok, SC
    Crum, CP
    Welch, WR
    Hecht, JL
    [J]. CANCER RESEARCH, 2005, 65 (06) : 2162 - 2169